Aptol Pharma ApS — Credit Rating and Financial Key Figures

CVR number: 39308967
Thad Jones Vej 6, 2450 København SV
aptolpharm@gmail.com
tel: 26784520
aptolpharma.com

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
External services- 137.00
Gross profit- 137.00- 421.54414.462.44
Employee benefit expenses- 304.06-72.62- 130.62
EBIT- 441.06- 421.54341.84- 128.17
Other financial income164.750.82-0.01
Other financial expenses282.79-0.13-0.24-0.00-3.11
Pre-tax profit6.47-0.13- 420.96341.84- 131.29
Income taxes-8.9486.60-33.86
Net earnings-2.46-0.13- 334.36307.98- 131.29

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables26.9420.34
Current deferred tax assets86.60
Short term receivables total26.9486.6020.34
Cash and bank deposits50.000.0017.05163.4428.01
Cash and cash equivalents50.000.0017.05163.4428.01
Balance sheet total (assets)50.0026.94103.64163.4448.35

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital50.0050.0050.0050.0050.00
Retained earnings2.46-32.54-32.66- 367.03-59.05
Profit of the financial year-2.46-0.13- 334.36307.98- 131.29
Shareholders equity total50.0017.34- 317.03-9.05- 140.34
Non-current liabilities total
Current trade creditors393.63
Short-term deferred tax liabilities33.8636.46
Other non-interest bearing current liabilities9.6127.04138.62152.22
Current liabilities total9.61420.67172.48188.68
Balance sheet total (liabilities)50.0026.94103.64163.4448.35
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.